4.10.28.3Vertical
Vascular Surgery Group Practices
Multi-physician vascular surgery practices providing open and endovascular surgical treatment for peripheral arterial disease, aortic aneurysm, and carotid artery disease.
Market snapshot
These figures describe Vascular Surgery & Vein Care (4.10.28), the segment that Vascular Surgery Group Practices sits within. They are not figures for Vascular Surgery Group Practices on its own.
FragmentationConsolidatingEstimate
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so vascular and vein care is not separately sized.
Business model & economics
Revenue model
Procedure and OBL reimbursement; cash-pay vein care
Key economics
- Recurring revenue
- Low–Moderate
- EBITDA margin
- 20–30% with OBL ancillaries
- Capex intensity
- Moderate
procedure-driven
Characteristics
- Office-based labs drive procedural economics.
- Cash-pay vein and aesthetic treatment upside.
- OBL reimbursement and utilization scrutiny are risks.
M&A deal context
Deal activityModerate
Who’s acquiring
- PE-backed vascular/vein platforms
- OBL-focused consolidators
- Specialty MSOs
What’s driving deals
- Roll-up for OBL and procedural economics.
- Aging, diabetes, and PAD demand.
- Reimbursement and utilization dynamics.
Find Vascular Surgery Group Practices acquisition targets
Search Acquisera’s index for companies classified under Vascular Surgery Group Practices (4.10.28.3) and build a targeted deal pipeline.
Search companies